文献速递小儿神经外科与脑积水神经重症

裂隙脑室综合征的管理:32例手术治疗患者的单中心病例系列

Management of Slit Ventricle Syndrome: A Single-Center Case Series of 32 Surgically Treated Patients.
PubMed 文献 · World Neurosurg · 2021-11-06

该单中心病例系列回顾了48例严重裂隙脑室综合征(SVS)住院患者,其中37例带可调压阀(P-valve)者先尝试调压,21例无效需手术;另11例无P-valve者亦需手术。共32例接受分流管外置后基于颅内压和脑室大小行阀置换或内镜下第三脑室底造瘘。手术死亡率3%,主要并发症6%,完全缓解55%、改善32%、无效或恶化13%。

要点

  • 32例严重SVS患者接受手术,术式包括分流管外置后阀置换或内镜下第三脑室底造瘘。
  • 手术死亡率3%,主要并发症6%,完全缓解55%、改善32%、无效或恶化13%。
  • 儿童年龄、无并发症的分流病程和短SVS病史为显著有利指标。

核心结论

  • SVS管理仍困难,但本研究识别出可能改善结局的因素,如更广泛使用P-valve治疗脑积水、及时诊断过度引流以及更早、更积极处理SVS的指征。

研究设计与样本

  • 单中心病例系列,10年期间共48例严重SVS住院患者,其中32例接受手术治疗。

主要发现

  • 37例带可调压阀(P-valve)者先尝试调压,21例无效需手术;另11例无P-valve者亦需手术。
  • 手术死亡率3%,主要并发症6%。
  • 完全缓解55%,改善32%,无效或恶化13%。
  • 仅1例在内镜下第三脑室底造瘘后摆脱分流依赖。
  • Medos与ProGrav阀结局相当,而ProSa在选定病例中起决定作用。

临床怎么用

  • 对带可调压阀的SVS患者可先尝试调压,无效者再考虑手术。
  • 手术方式依据颅内压和脑室大小选择阀置换或内镜下第三脑室底造瘘。
  • 新阀可选ProGav Mietke(Aesculap)或Medos Codman(Integra),各配抗虹吸系统;选定病例可用可调抗虹吸系统ProSa Mietke。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Slit ventricle syndrome (SVS) is an iatrogenic disease occurring in patients with ventriculoperitoneal shunt. This article reports the management modalities and results in a case series from a single center. METHODS: We reviewed a series 48 hospitalized patients with severe SVS whom we managed in a 10-year period. Thirty-seven patients harboring programmable valves (P-valves) first underwent attempts at valve reprogramming. This treatment produced no effect in 21 patients, who therefore required surgical treatment. Surgery was also required by 11 patients without P-valve. Accordingly, 32 patients had to be operatively treated by shunt externalization followed by valve replacement or endoscopic third ventriculostomy basing on intracranial pressure and ventricular size. The new valve was either ProGav Mietke (Aesculap) or Medos Codman (Integra), each equipped with its own antisiphon system. In selected cases, a programmable antisiphon system (ProSa Mietke) was used. RESULTS: Surgical mortality was 3% and major morbidity accounted for 6%. Complete resolution was obtained in 55% of cases, improvement in 32%, and no effect or worsening in 13%. Only 1 patient became shunt free after endoscopic third ventriculostomy. Medos and ProGrav provided comparable outcomes, whereas ProSa was determinant in selected cases. Pediatric age, uncomplicated shunt courses, and short SVS histories were significantly favorable indicators. CONCLUSIONS: SVS management remains problematic. However, this study individuated factors that may improve the outcome, such as wider use of P-valves to treat hydrocephalus, timely diagnosis of overdrainage, and earlier and more aggressive indications to manage SVS.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Auricchio AM, Bohnen A, Nichelatti M, et al. Management of Slit Ventricle Syndrome: A Single-Center Case Series of 32 Surgically Treated Patients. World Neurosurg. 2021. PMID: 34749014. doi:10.1016/j.wneu.2021.10.183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。